UNAUDITED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional paid-in capital	Accumulated deficit	Accumulated other comprehensive income/(loss)
Beginning balance (in shares) at Dec. 31, 2022		74,156
Beginning balance at Dec. 31, 2022	$ 363,044	$ 7	$ 378,006	$ (14,121)	$ (848)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(7,970)			(7,970)
Stock-based compensation	13,257		13,257
Exercise of stock options (in shares)		1
Exercise of stock options	10		10
Issuance of shares and payments of tax obligations resulted from net share settlement of vested stock awards (in shares)		739
Issuance of shares and payments of tax obligations resulted from net share settlement of vested stock awards	(8,951)		(8,951)
Foreign currency translation adjustments, net of tax	495				495
Ending balance (in shares) at Mar. 31, 2023		74,896
Ending balance at Mar. 31, 2023	359,885	$ 7	382,322	(22,091)	(353)
Beginning balance (in shares) at Dec. 31, 2023		75,887
Beginning balance at Dec. 31, 2023	382,907	$ 8	397,511	(15,886)	1,274
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,948)			(3,948)
Stock-based compensation	11,339		11,339
Exercise of stock options (in shares)		69
Exercise of stock options	260		260
Issuance of shares and payments of tax obligations resulted from net share settlement of vested stock awards (in shares)		565
Issuance of shares and payments of tax obligations resulted from net share settlement of vested stock awards	(7,569)		(7,569)
Foreign currency translation adjustments, net of tax	(178)				(178)
Ending balance (in shares) at Mar. 31, 2024		76,521
Ending balance at Mar. 31, 2024	$ 382,811	$ 8	$ 401,541	$ (19,834)	$ 1,096